We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $30.5B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$17.2B
AUM Growth
-$1.83B
Cap. Flow
-$1.5B
Cap. Flow %
-8.7%
Top 10 Hldgs %
69.28%
Holding
65
New
3
Increased
3
Reduced
10
Closed
10

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.15B
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$110M
3
ILMN icon
Illumina
ILMN
+$73.1M
4
JD icon
JD.com
JD
+$65.1M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.18%
2 Communication Services 20.05%
3 Healthcare 14.09%
4 Financials 11.93%
5 Materials 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
26
JD.com
JD
$41.1B
$139M 0.81%
5,317,867
-1,988,705
-27% -$65.1M
PTLA
27
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$138M 0.8%
5,174,168
AMZN icon
28
Amazon
AMZN
$2.52T
$132M 0.77%
1,317,360
HDB icon
29
HDFC Bank
HDB
$119B
$131M 0.76%
5,564,660
FTCH
30
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$122M 0.71%
+4,470,415
New +$127M
GPN icon
31
Global Payments
GPN
$22.5B
$112M 0.65%
876,176
VNET
32
VNET Group
VNET
$2.06B
$109M 0.63%
10,778,004
CHRS icon
33
Coherus Oncology
CHRS
$227M
$108M 0.63%
6,556,116
AQUA
34
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$107M 0.62%
6,037,705
DNLI icon
35
Denali Therapeutics
DNLI
$3.77B
$95.9M 0.56%
4,410,457
AVGO icon
36
Broadcom
AVGO
$1.83T
$92.8M 0.54%
3,760,500
-160,000
-4% -$3.59M
CBPO
37
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$79.2M 0.46%
990,000
QTTB icon
38
Q32 Bio
QTTB
$476M
$73.6M 0.43%
178,905
IBN icon
39
ICICI Bank
IBN
$107B
$73.4M 0.43%
8,639,819
TOUR
40
Tuniu
TOUR
$57.3M
$58.8M 0.34%
819,444
REGN icon
41
Regeneron Pharmaceuticals
REGN
$69.9B
$51.1M 0.3%
126,351
-64,270
-34% -$24.5M
KREF
42
KKR Real Estate Finance Trust
KREF
$473M
$49.2M 0.29%
2,439,024
EMWP
43
DELISTED
Eros Media World PLC
EMWP
$33.2M 0.19%
137,766
BP icon
44
BP
BP
$111B
$27.5M 0.16%
+625,217
New +$26.1M
NTLA icon
45
Intellia Therapeutics
NTLA
$1.56B
$22.6M 0.13%
790,527
ACIU icon
46
AC Immune
ACIU
$231M
$20.9M 0.12%
2,614,095
+1,276,595
+95% +$12.8M
ILMN icon
47
Illumina
ILMN
$29.1B
$20.4M 0.12%
57,005
-228,019
-80% -$73.1M
ASLN
48
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$11.4M 0.07%
35,562
EMR icon
49
Emerson Electric
EMR
$83.7B
$9.49M 0.06%
123,908
ROK icon
50
Rockwell Automation
ROK
$51.7B
$8.33M 0.05%
44,409

Similar funds

Temasek Holdings's Q3 2018 Portfolio in Review

As of Q3 2018, Temasek Holdings held 65 positions worth $17.2B, down 9.6% from $19B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Temasek Holdings withdrew a net $1.5B in Q3 2018, closing 10 positions and reducing 10 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $41.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Temasek Holdings opened a new position in Farfetch Limited Class A Ordinary Shares worth $122M.

  • Temasek Holdings's largest Q3 2018 buy was Farfetch Limited Class A Ordinary Shares: 4,470,415 shares worth $122M.
  • Temasek Holdings added most to Royal Dutch Shell PLC ADS Class B in Q3 2018, an estimated $42.9M increase.
  • Temasek Holdings's biggest Q3 2018 reduction was Alibaba, cutting an estimated $1.15B.
  • Temasek Holdings fully exited Vertex Pharmaceuticals in Q3 2018, selling an estimated $41.6M.
  • Temasek Holdings's ten largest holdings make up 69% of its $17.2B portfolio in Q3 2018.
  • Temasek Holdings opened 3 new positions and closed 10 in Q3 2018.
  • Temasek Holdings's portfolio value fell 9.6% quarter-over-quarter to $17.2B.

Based on Temasek Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.